link to RWJMS home page
Banner Image Here


The Cystic Fibrosis Center at Rutgers, Robert Wood Johnson Medical School is a designated center for the TDN (Therapeutics Development Network). 

The Cystic Fibrosis Therapeutics Development Network (TDN) is the largest cystic fibrosis clinical trials network in the world.

The TDN brings together experts from across the United States to evaluate the safety and effectiveness of new CF therapies through clinical studies. We work continually to improve research methods and pursue new areas of scientific inquiry.

Through efficient study design, optimized clinical trial execution and high-quality data, the TDN helps speed the delivery of new and better therapies to people with CF.

This center, along with many CF centers around the country, is involved in multiple clinical trials to develop new drugs to treat this disease.  For more information on CF related research, please go to:


Therapeutics Development Network (TDN) | Cystic Fibrosis Foundation Therapeutics


If you have questions about your eligibility to participate in a research study, please talk to your CF team.


To search clinical trials, you can also go to Clinical Trial Finder